Osteocalcina e patologia endocrina.

Translated title of the contribution: Osteocalcin and endocrine pathology

A. Sartorio, A. Conti

Research output: Contribution to journalArticle

Abstract

The field of metabolic bone diseases has recently received useful information from the examination of the role of new collagenous and non-collagenous bone proteins, such as osteocalcin (also called bone Gla-protein) and osteonectin. It appears that at present, serum osteocalcin is the one bone protein that has the most promise for assisting in the diagnosis and management of high turnover metabolic bone disease states. Since endocrine diseases are frequently associated with altered bone turnover due to a disequilibrium between formation and bone resorption, we examine the role of osteocalcin, a specific marker of osteoblastic activity, in these clinical conditions.

Original languageItalian
Pages (from-to)185-192
Number of pages8
JournalMinerva Endocrinologica
Volume14
Issue number3
Publication statusPublished - Jul 1989

Fingerprint

Osteocalcin
Pathology
Metabolic Bone Diseases
Osteonectin
Endocrine System Diseases
Bone and Bones
Bone Remodeling
Bone Resorption
Proteins
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Osteocalcina e patologia endocrina. / Sartorio, A.; Conti, A.

In: Minerva Endocrinologica, Vol. 14, No. 3, 07.1989, p. 185-192.

Research output: Contribution to journalArticle

Sartorio, A & Conti, A 1989, 'Osteocalcina e patologia endocrina.', Minerva Endocrinologica, vol. 14, no. 3, pp. 185-192.
Sartorio, A. ; Conti, A. / Osteocalcina e patologia endocrina. In: Minerva Endocrinologica. 1989 ; Vol. 14, No. 3. pp. 185-192.
@article{af55ce947ed843398e86956a5fb28ed7,
title = "Osteocalcina e patologia endocrina.",
abstract = "The field of metabolic bone diseases has recently received useful information from the examination of the role of new collagenous and non-collagenous bone proteins, such as osteocalcin (also called bone Gla-protein) and osteonectin. It appears that at present, serum osteocalcin is the one bone protein that has the most promise for assisting in the diagnosis and management of high turnover metabolic bone disease states. Since endocrine diseases are frequently associated with altered bone turnover due to a disequilibrium between formation and bone resorption, we examine the role of osteocalcin, a specific marker of osteoblastic activity, in these clinical conditions.",
author = "A. Sartorio and A. Conti",
year = "1989",
month = "7",
language = "Italian",
volume = "14",
pages = "185--192",
journal = "Minerva Endocrinologica",
issn = "0391-1977",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Osteocalcina e patologia endocrina.

AU - Sartorio, A.

AU - Conti, A.

PY - 1989/7

Y1 - 1989/7

N2 - The field of metabolic bone diseases has recently received useful information from the examination of the role of new collagenous and non-collagenous bone proteins, such as osteocalcin (also called bone Gla-protein) and osteonectin. It appears that at present, serum osteocalcin is the one bone protein that has the most promise for assisting in the diagnosis and management of high turnover metabolic bone disease states. Since endocrine diseases are frequently associated with altered bone turnover due to a disequilibrium between formation and bone resorption, we examine the role of osteocalcin, a specific marker of osteoblastic activity, in these clinical conditions.

AB - The field of metabolic bone diseases has recently received useful information from the examination of the role of new collagenous and non-collagenous bone proteins, such as osteocalcin (also called bone Gla-protein) and osteonectin. It appears that at present, serum osteocalcin is the one bone protein that has the most promise for assisting in the diagnosis and management of high turnover metabolic bone disease states. Since endocrine diseases are frequently associated with altered bone turnover due to a disequilibrium between formation and bone resorption, we examine the role of osteocalcin, a specific marker of osteoblastic activity, in these clinical conditions.

UR - http://www.scopus.com/inward/record.url?scp=0024693934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024693934&partnerID=8YFLogxK

M3 - Articolo

C2 - 2695817

AN - SCOPUS:0024693934

VL - 14

SP - 185

EP - 192

JO - Minerva Endocrinologica

JF - Minerva Endocrinologica

SN - 0391-1977

IS - 3

ER -